Search

Displaying results 5951 - 5960 of 10000 in total
  1. Drug

    Meplazumab

    go.drugbank.com/drugs/DB16465
    Investigational

    Meplazumab is a humanized anti-CD147 antibody being investigated as an add-on therapy in patients with COVID-19 pneumonia.

  2. Drug

    KIN-3248

    go.drugbank.com/drugs/DB17587
    Investigational

    [A257714] While effective, disease progression may occur 6 to 8 months after treatment with currently approved FGFR inhibitors is started, and this effect is usually associated with on-target resistance … KIN-3248 is a small molecule that targets and inhibits oncogenic fibroblast growth factor receptors (FGFRs).

  3. Drug

    Tanomastat

    go.drugbank.com/drugs/DB06276
    Experimental

  4. Drug

    Pramiconazole

    go.drugbank.com/drugs/DB06295
    Experimental

  5. Drug

    LX-2931

    go.drugbank.com/drugs/DB06297
    Investigational

  6. Drug

    Ilodecakin

    go.drugbank.com/drugs/DB06449
    Investigational

  7. Drug

    Odiparcil

    go.drugbank.com/drugs/DB06609
    Investigational

  8. Drug

    Sivifene

    go.drugbank.com/drugs/DB05686
    Investigational

  9. Drug

    Quinupristin

    go.drugbank.com/drugs/DB01369
    Approved

    The combination of the two components acts synergistically and is more effective in vitro than each component alone. … Quinupristin/dalfopristin is a combination of two antibiotics used to treat infections by staphylococci and by vancomycin-resistant Enterococcus faecium.

  10. Drug

    Padimate A

    go.drugbank.com/drugs/DB11229
    ApprovedWithdrawn

    In Europe this chemical was withdrawn in 1989 for unstated reasons and in the US it was never approved for use in sunscreens. … Padimate A is an ester derivative of PABA and an ingredient in some sunscreens.